ui.skipToMain
Comercializadora de Servicios Médicos Cubanos, S.A.SMC Salud
Eastern United States flagFor Eastern United States Families
Regional Hub

Diabetic Foot Ulcer Treatment in Cuba in Eastern United States

The Eastern United States — spanning from Florida and Texas in the south to Maryland and New York in the north — is home to over 3.2 million Americans living with Alzheimer's. This broad region encompasses the nation's largest senior populations, significant African American and Hispanic communities, and high diabetes rates that compound cognitive decline. Miami, Tampa, Fort Lauderdale, and Houston offer direct charter flights to Havana, while Atlanta, Charlotte, Baltimore, and New Orleans provide connecting flight options.

Diabetic Foot Ulcer Treatment in Cuba in Cuba for Eastern United States patients

18.0M

Eastern United States residents with diabetes

14

states in region

1–6 hours (varies by departure city)

to Havana

Direct

flights available

Heberprot-P for Diabetic Foot Ulcers Across Eastern United States

Heberprot-P is Cuba's pioneering treatment for diabetic foot ulcers. Developed by the Center for Genetic Engineering and Biotechnology (CIGB), it contains recombinant human epidermal growth factor (rEGF) — a protein that stimulates cell growth and new blood vessel formation in wounds. It is administered via intralesional injection directly into the ulcer bed, typically 3 times per week, combined with surgical debridement and specialized dressings.

Heberprot-P is not FDA-approved and is not available in the United States. It is registered in approximately 20 countries and has been used in Cuba for over a decade. The treatment is designed for chronic diabetic foot ulcers — particularly Wagner grade 1–3 ulcers that have not responded to standard wound care (debridement, off-loading, moisture dressings) after 4+ weeks.

The treatment program at Cuban diabetic foot centers includes comprehensive vascular assessment (Doppler, angiography if indicated), infection management (wound cultures, targeted antibiotics), surgical debridement, Heberprot-P intralesional injections, off-loading (total contact casting or specialized footwear), specialized dressings, and rehabilitation. The goal is wound healing and amputation prevention — not a cure for diabetes. Treatment suitability is determined after individual medical evaluation.

Heberprot-P is not FDA-approved and is not available in the United States. It is not a cure for diabetes. Treatment aims to promote wound healing and prevent amputation. Treatment suitability is determined after individual medical evaluation. Individual outcomes vary.

State-by-State Guides

Diabetic Foot Ulcer Treatment in Cuba by State in Eastern United States

Select your state for detailed information about diabetic foot ulcer treatment in cuba options, travel logistics, and state-specific resources.

Travel from Eastern United States

Getting to Havana from Eastern United States

Major Departure Airports

  • Miami (MIA)
  • Tampa (TPA)
  • Fort Lauderdale (FLL)
  • Houston (IAH)
  • Dallas (DFW)
  • Atlanta (ATL)
  • Charlotte (CLT)
  • Baltimore (BWI)
  • New Orleans (MSY)

Travel time: 1–6 hours (varies by departure city)

Travel Authorization

  • • U.S. citizens can travel to Cuba under approved categories
  • • SMC Salud provides letter of medical necessity
  • • Treatment confirmation documentation included
  • • Airport reception and ground transport in Havana
  • • English-speaking coordinators throughout your stay

Frequently Asked Questions

Questions from Eastern United States Families

Yes. U.S. citizens can travel to Cuba under approved categories. SMC Salud provides all necessary documentation, including the letter of medical necessity and treatment confirmation, to support travel authorization. Our team guides you through the entire process to ensure compliance with all regulations.

Ready to Explore Diabetic Foot Ulcer Treatment in Cuba in Cuba?

Submit your medical records for a complimentary review. Families across Eastern United States receive a personalized treatment proposal within 5–10 business days.